Novartis Vaccines & Diagnostics Inc (NVDI) has sought to press Aventis Pharma Ltd (APL) into agreeing to arbitration in a dispute involving the marketing of an anti-rabies vaccine.
You must be a
to read this content, please
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.